Literature DB >> 16781987

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

Alex Iranzo1, José Luis Molinuevo, Joan Santamaría, Mónica Serradell, María José Martí, Francesc Valldeoriola, Eduard Tolosa.   

Abstract

BACKGROUND: Rapid-eye-movement (REM) sleep behaviour disorder (RBD) is a parasomnia characterised by dream-enacting behaviours related to unpleasant dreams and loss of muscle atonia during REM sleep. RBD may be idiopathic or associated with neurological disease. Available data suggest that in some cases RBD might be the initial manifestation of a neurodegenerative disease. We sought to determine the frequency and nature of neurological disorders developing in patients diagnosed with idiopathic RBD at our sleep centre.
METHODS: We retrospectively assessed 44 consecutive patients (39 men and five women with a mean age of 74 years), with at least 2 years of clinical follow-up after a diagnosis of idiopathic RBD, through a detailed clinical history, complete neurological examination, rating scales of parkinsonism, and neuropsychological tests.
FINDINGS: 20 (45%) patients developed a neurological disorder after a mean of 11.5 years from the reported onset of RBD and a mean follow-up of 5.1 years from the diagnosis of idiopathic RBD at our sleep centre. Emerging disorders were Parkinson's disease in nine patients, dementia with Lewy bodies in six, multiple system atrophy with predominant cerebellar syndrome in one, and mild cognitive impairment in four in whom visuospatial dysfunction was prominent. Patients with longer clinical follow-up developed a neurological disease (OR 1.512, 95% CI 1.105-2.069; p=0.010).
INTERPRETATION: Our study indicates that in people presenting to sleep centres, RBD often antedates the development of a neurodegenerative disorder. Close follow-up of patients with idiopathic RBD could enable early detection of neurodegenerative disease. This finding may be of great interest when early effective treatment strategies and neuroprotective drugs become available.

Entities:  

Mesh:

Year:  2006        PMID: 16781987     DOI: 10.1016/S1474-4422(06)70476-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  214 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 3.  Diagnostic tools for REM sleep behavior disorder.

Authors:  Ariel B Neikrug; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2011-12-14       Impact factor: 11.609

4.  Dementia with lewy bodies: diagnosis and management for primary care providers.

Authors:  Melanie Zupancic; Aman Mahajan; Kamna Handa
Journal:  Prim Care Companion CNS Disord       Date:  2011

5.  When is it dementia?

Authors:  Roy Yaari; Adam S Fleisher; Anna D Burke; Helle Brand; Jan Dougherty; James D Seward; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  Respect for muscle.

Authors:  Donald L Bliwise; David B Rye
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

Review 7.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

8.  Night-to-night variability of muscle tone, movements, and vocalizations in patients with REM sleep behavior disorder.

Authors:  Fanny Cygan; Delphine Oudiette; Laurène Leclair-Visonneau; Smaranda Leu-Semenescu; Isabelle Arnulf
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

9.  A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study.

Authors:  Ronald B Postuma; Isabelle Arnulf; Birgit Hogl; Alex Iranzo; Tomoyuki Miyamoto; Yves Dauvilliers; Wolfgang Oertel; Yo-El Ju; Monica Puligheddu; Poul Jennum; Amelie Pelletier; Christina Wolfson; Smaranda Leu-Semenescu; Birgit Frauscher; Masayuki Miyamoto; Valerie Cochen De Cock; Marcus M Unger; Karin Stiasny-Kolster; Maria Livia Fantini; Jacques Y Montplaisir
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

10.  Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?

Authors:  Friederike Sixel-Döring; Ellen Trautmann; Brit Mollenhauer; Claudia Trenkwalder
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.